Researchers conduct deep brain stimulation in Alzheimer's patient

February 1, 2013, University of Florida

(Medical Xpress)—Researchers at the University of Florida have performed deep brain stimulation on a patient with Alzheimer's disease as part of a clinical trial studying whether the treatment can slow progression of the disease.

Called the Advance Study, the multicenter clinical trial will evaluate whether using electrodes to stimulate a part of the brain called the fornix can slow and improve cognitive function in patients in the early stages of Alzheimer's disease. The trial is taking place at four sites across the United States, including UF.

"The goal of treating Alzheimer's disease with neuromodulation is to try to enhance what patients have and slow down memory loss and the process of the disease so they can have a few more years of good function," said Dr. Michael Okun, co-director of the UF Center for Movement Disorders and Neurorestoration and a site principal investigator for the study. "This is a potentially exciting symptomatic therapy."

Characterized by and a steady decline in , Alzheimer's disease affects as many as 5.1 million Americans, according to the National Institute on Aging.

is used to treat a variety of conditions, including Parkinson's disease, dystonia and Tourette syndrome. In the procedure, researchers carefully place electrodes in specific regions of the brain. When these electrodes are turned on, they send that prompt a therapeutic response.

"In Alzheimer's patients there is a very slow loss of ," Okun said. "These slow changes that happen in the brain lead to the clinical symptoms. The idea is that we are going to try and modulate the circuits to see if we can improve some of the symptoms."

Researchers decided to test deep in the fornix—a part of the brain that connects the hippocampus to the hypothalamus—after the accidental discovery that stimulating that region of the brain provoked vivid memories in patients, Okun said.

The therapy is being tested at four sites: UF, Toronto Western Hospital, the Banner Alzheimer's Institute and Johns Hopkins University. Overall, 20 patients will be enrolled in the trial, although the electrodes will not be turned on in all the participants, Okun said.

"This is the best way for us to tell if there is a real response versus a placebo response," he said. "It's very tricky to measure memory and cognition."

Aside from testing the effectiveness of the therapy, researchers also are closely examining how stimulating the brain affects the course of Alzheimer's disease and whether it prompts changes in oxygen, in glucose levels and in blood flow.

"What we have seen so far is there are very interesting changes in blood flow," Okun said. "It's very early and it is hard to judge these things just on pictures but the pictures look very interesting. There is definitely something going on in the circuit."

Explore further: In US first, Johns Hopkins surgeons implant brain 'pacemaker' for Alzheimer's disease

Related Stories

In US first, Johns Hopkins surgeons implant brain 'pacemaker' for Alzheimer's disease

December 5, 2012
Researchers at Johns Hopkins Medicine in November surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer's disease, the first such operation in the United States. The device, ...

Ohio State implants first brain pacemaker to treat Alzheimer's

January 23, 2013
During a five-hour surgery last October at The Ohio State University Wexner Medical Center, Kathy Sanford became the first Alzheimer's patient in the United States to have a pacemaker implanted in her brain.

Researchers study mitochondrial function, potential new therapeutic target for Alzheimer's disease

February 15, 2012
Researchers at Rush University Medical Center are conducting an early phase clinical trial of a novel drug therapy for patients with dementia due to Alzheimer's disease. The drug is a new compound called MSDC-0160, which ...

Deep brain stimulation may hold promise for mild Alzheimer's disease

May 7, 2012
A study on a handful of people with suspected mild Alzheimer's disease (AD) suggests that a device that sends continuous electrical impulses to specific "memory" regions of the brain appears to increase neuronal activity. ...

Electrical stimulation of brain boosts birth of new cells, may improve memory

September 20, 2011
Stimulating a specific region of the brain leads to the production of new brain cells that enhance memory, according to an animal study in the September 21 issue of The Journal of Neuroscience. The findings show how deep ...

Recommended for you

Energy storehouses in the brain may be source of Alzheimer's, targets of new therapy

January 23, 2018
Alzheimer's disease, a severely debilitating and ultimately fatal brain disorder, affects millions worldwide. To date, clinical efforts to find a cure or adequate treatment have met with dispiriting failure.

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.